KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes DURHAM, N.C.–(BUSINESS WIRE)– KBI Biopharma, Inc. (KBI), a JSR Life Sciences company,...